513430 Stock Overview
Primarily engages in the trading of pharmaceutical and medical goods in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Maitri Enterprises Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹47.00 |
| 52 Week High | ₹51.34 |
| 52 Week Low | ₹20.10 |
| Beta | 0.20 |
| 11 Month Change | -3.69% |
| 3 Month Change | 27.10% |
| 1 Year Change | 101.54% |
| 33 Year Change | 369.53% |
| 5 Year Change | 506.45% |
| Change since IPO | 101.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| 513430 | IN Commercial Services | IN Market | |
|---|---|---|---|
| 7D | -3.7% | 0.5% | 0.3% |
| 1Y | 101.5% | 15.0% | 27.3% |
Return vs Industry: 513430 exceeded the Indian Commercial Services industry which returned 14% over the past year.
Return vs Market: 513430 exceeded the Indian Market which returned 27.2% over the past year.
Price Volatility
| 513430 volatility | |
|---|---|
| 513430 Average Weekly Movement | n/a |
| Commercial Services Industry Average Movement | 6.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 513430's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine 513430's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 43 | Jaikishan Ambwani | www.maitrienterprises.com |
Maitri Enterprises Limited primarily engages in the trading of pharmaceutical and medical goods in India. The company operates through two segments, Pharmaceutical Goods and Sale of Service by Way of Works Contract. It offers pharmaceuticals products, including generic and non-generic medicines.
Maitri Enterprises Limited Fundamentals Summary
| 513430 fundamental statistics | |
|---|---|
| Market cap | ₹206.80m |
| Earnings (TTM) | ₹1.35m |
| Revenue (TTM) | ₹273.90m |
153.8x
P/E Ratio0.8x
P/S RatioIs 513430 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 513430 income statement (TTM) | |
|---|---|
| Revenue | ₹273.90m |
| Cost of Revenue | ₹227.80m |
| Gross Profit | ₹46.10m |
| Other Expenses | ₹44.76m |
| Earnings | ₹1.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.31 |
| Gross Margin | 16.83% |
| Net Profit Margin | 0.49% |
| Debt/Equity Ratio | 154.6% |
How did 513430 perform over the long term?
See historical performance and comparison